Expand NGNE Menu
NGNE MENU

NGNE Latest Press Releases

-- December 4, 2025 --

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:01 PM

-- November 13, 2025 --

Neurogene Reports Third Quarter 2025 Financial Results and Highlights Recent Updates Business Wire 5:10 PM

-- November 12, 2025 --

Neurogene Reports Positive Interim Data in Pediatric Cohort from NGN-401 Gene Therapy Trial for Rett Syndrome Business Wire 4:01 PM

-- November 6, 2025 --

Neurogene Announces First Participant Dosed in Embolden Registrational Trial of NGN-401 Gene Therapy for Rett Syndrome Business Wire 7:30 AM

-- November 5, 2025 --

Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:01 PM

-- October 9, 2025 --

Neurogene Announces Positive Regulatory Update for NGN-401 Gene Therapy in Rett Syndrome with Plans to Initiate Dosing in Embolden Registrational Trial in Q4 2025 Business Wire 7:00 AM

-- October 8, 2025 --

Neurogene to Participate in H.C. Wainwright Genetic Medicines Virtual Conference Business Wire 7:30 AM

-- October 3, 2025 --

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:01 PM

-- September 5, 2025 --

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:01 PM

-- August 11, 2025 --

Neurogene Reports Second Quarter 2025 Financial Results and Highlights Recent Updates Business Wire 4:10 PM

-- August 8, 2025 --

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:01 PM
Market Data Delayed 15 Minutes